Índice Bovespa

US Dollar vs BRL

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

PMVP PMV Pharmaceuticals Inc

1,69

0,075 (4,64%)

25 Jun 2024 - Fechado

Atrasado em 15 minutos

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
ny20006675x3_ars.pdf

PMV Pharmaceuticals (NASDAQ:PMVP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Click aqui para mais gráficos PMV Pharmaceuticals.

PMV Pharmaceuticals (NASDAQ:PMVP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024

Click aqui para mais gráficos PMV Pharmaceuticals.

Notícias Pmv Pharmaceuticals, Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 10 de Junho de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Sexta, 7 de Junho de 2024 (3 semanas atrás) • Edgar (US Regulatory)

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
Quinta, 30 de Maio de 2024 (4 semanas atrás) • GlobeNewswire Inc.

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
Quarta, 29 de Maio de 2024 (4 semanas atrás) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Quinta, 9 de Maio de 2024 (2 meses atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Quinta, 9 de Maio de 2024 (2 meses atrás) • Edgar (US Regulatory)

PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
Quinta, 9 de Maio de 2024 (2 meses atrás) • GlobeNewswire Inc.

PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
Quarta, 27 de Março de 2024 (3 meses atrás) • GlobeNewswire Inc.

PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
Segunda, 18 de Março de 2024 (3 meses atrás) • GlobeNewswire Inc.

Form 8-K - Current report
Quinta, 29 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory)

PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
Quinta, 29 de Fevereiro de 2024 (4 meses atrás) • GlobeNewswire Inc.

PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
Segunda, 26 de Fevereiro de 2024 (4 meses atrás) • GlobeNewswire Inc.

Mais Notícias de Pmv Pharmaceuticals, Inc.

Africa Oil (PK)

Bank of Montreal Capped ...

NLBNPIT1USZ8 20991231 11...

Gryphon Digital Mining

NLBNPIT1Y920 20240620 40...

NLBNPIT1THX8 20240621 220

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições